Issue 3/2012
Content (42 Articles)
What’s new since Hippocrates? Preventing type 2 diabetes by physical exercise and diet
J. A. Hawley, M. J. Gibala
What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review
M. Chimen, A. Kennedy, K. Nirantharakumar, T. T. Pang, R. Andrews, P. Narendran
Measures of health-related quality of life in diabetes-related foot disease: a systematic review
F. R. A. Hogg, G. Peach, P. Price, M. M. Thompson, R. J. Hinchliffe
Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis
P. Vejakama, A. Thakkinstian, D. Lertrattananon, A. Ingsathit, C. Ngarmukos, J. Attia
Relationship of exercise volume to improvements of quality of life with supervised exercise training in patients with type 2 diabetes in a randomised controlled trial: the Italian Diabetes and Exercise Study (IDES)
A. Nicolucci, S. Balducci, P. Cardelli, S. Cavallo, S. Fallucca, A. Bazuro, P. Simonelli, C. Iacobini, S. Zanuso, G. Pugliese
Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes
A. R. Cooper, S. Sebire, A. A. Montgomery, T. J. Peters, D. J. Sharp, N. Jackson, K. Fitzsimons, C. M. Dayan, R. C. Andrews
The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial
A. Rafnsson, F. Böhm, M. Settergren, A. Gonon, K. Brismar, J. Pernow
The course of depressive symptoms in primary care patients with type 2 diabetes: results from the Diabetes, Depression, Type D Personality Zuidoost-Brabant (DiaDDZoB) Study
G. Nefs, F. Pouwer, J. Denollet, V. Pop
Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study
T. Lind, I. Waernbaum, Y. Berhan, G. Dahlquist
Insulin resistance and arterial stiffness in healthy adolescents and young adults
E. M. Urbina, Z. Gao, P. R. Khoury, L. J. Martin, L. M. Dolan
The joint association of physical activity and glycaemic control in predicting cardiovascular death and all-cause mortality in the US population
J. I. Reddigan, M. C. Riddell, J. L. Kuk
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
S. Zoungas, J. Chalmers, T. Ninomiya, Q. Li, M. E. Cooper, S. Colagiuri, G. Fulcher, B. E. de Galan, S. Harrap, P. Hamet, S. Heller, S. MacMahon, M. Marre, N. Poulter, F. Travert, A. Patel, B. Neal, M. Woodward
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
P. Blin, R. Lassalle, C. Dureau-Pournin, B. Ambrosino, M. A. Bernard, A. Abouelfath, H. Gin, C. Le Jeunne, A. Pariente, C. Droz, N. Moore
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
T. P. van Staa, D. Patel, A. M. Gallagher, M. L. de Bruin
Novel versus traditional risk markers for diabetic retinopathy
M. B. Sasongko, T. Y. Wong, T. T. Nguyen, J. E. Shaw, A. J. Jenkins, J. J. Wang
Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility—Reykjavik Study (AGES-R)
E. Gunnlaugsdottir, S. Halldorsdottir, R. Klein, G. Eiriksdottir, B. E. Klein, R. Benediktsson, T. B. Harris, L. J. Launer, T. Aspelund, V. Gudnason, M. F. Cotch, F. Jonasson
Age at menarche is associated with prediabetes and diabetes in women (aged 32–81 years) from the general population: the KORA F4 Study
D. Stöckl, A. Döring, A. Peters, B. Thorand, M. Heier, C. Huth, H. Stöckl, W. Rathmann, B. Kowall, C. Meisinger
The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study
K. Lukacs, N. Hosszufalusi, E. Dinya, M. Bakacs, L. Madacsy, P. Panczel
INS GFP/w human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells
S. J. Micallef, X. Li, J. V. Schiesser, C. E. Hirst, Q. C. Yu, S. M. Lim, M. C. Nostro, D. A. Elliott, F. Sarangi, L. C. Harrison, G. Keller, A. G. Elefanty, E. G. Stanley
Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets
C. Dai, M. Brissova, Y. Hang, C. Thompson, G. Poffenberger, A. Shostak, Z. Chen, R. Stein, A. C. Powers
Lentivirus shRNA Grb10 targeting the pancreas induces apoptosis and improved glucose tolerance due to decreased plasma glucagon levels
B. Doiron, W. Hu, L. Norton, R. A. DeFronzo
Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus
A. Chan, E. J. Barrett, S. M. Anderson, B. P. Kovatchev, M. D. Breton
Postprandial whole-body glycolysis is similar in insulin-resistant and insulin-sensitive non-diabetic humans
J. E. Galgani, E. Ravussin
The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells
L. Serrano-Marco, E. Barroso, I. El Kochairi, X. Palomer, L. Michalik, W. Wahli, M. Vázquez-Carrera
Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice
J. Levi, F. K. Huynh, H. C. Denroche, U. H. Neumann, M. M. Glavas, S. D. Covey, T. J. Kieffer
Increased metabolic rate and insulin sensitivity in male mice lacking the carcino-embryonic antigen-related cell adhesion molecule 2
P. R. Patel, S. K. Ramakrishnan, M. K. Kaw, C. K. Raphael, S. Ghosh, J. S. Marino, G. Heinrich, S. J. Lee, R. E. Bourey, J. W. Hill, D. Y. Jung, D. A. Morgan, J. K. Kim, S. K. Rahmouni, S. M. Najjar
Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)–nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction
R. Barazzoni, M. Zanetti, G. Gortan Cappellari, A. Semolic, M. Boschelle, E. Codarin, A. Pirulli, L. Cattin, G. Guarnieri
Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle
I. Chopra, H. F. Li, H. Wang, K. A. Webster
Small fibre dysfunction, microvascular complications and glycaemic control in type 1 diabetes: a case–control study
P. R. J. Vas, A. Q. Green, G. Rayman
Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease
J. M. Zheng, G. H. Yao, Z. Cheng, R. Wang, Z. H. Liu
TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition
C. E. Hills, E. Siamantouras, S. W. Smith, P. Cockwell, K.-K. Liu, P. E. Squires
Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy
R. Shahni, L. Gnudi, A. King, P. Jones, A. N. Malik
Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes
L. A. Maile, K. Gollahon, C. Wai, G. Byfield, M. E. Hartnett, D. Clemmons
Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology
A. K. Berner, O. Brouwers, R. Pringle, I. Klaassen, L. Colhoun, C. McVicar, S. Brockbank, J. W. Curry, T. Miyata, M. Brownlee, R. O. Schlingemann, C. Schalkwijk, A. W. Stitt
Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]
R. Ruiter, L. E. Visser, B. H. Ch. Stricker
Erratum to: Increased metabolic rate and insulin sensitivity in male mice lacking the carcino-embryonic antigen-related cell adhesion molecule 2
P. R. Patel, S. K. Ramakrishnan, M. K. Kaw, C. K. Raphael, S. Ghosh, J. S. Marino, G. Heinrich, S. J. Lee, R. E. Bourey, J. W. Hill, D. Y. Jung, D. A. Morgan, J. K. Kim, K. Rahmouni, S. M. Najjar
Erratum to: Audit of acute Charcot’s disease in the UK: the CDUK study
F. L. Game, R. Catlow, G. R. Jones, M. E. Edmonds, E. B. Jude, G. Rayman, W. J. Jeffcoate
Erratum to: Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes
M. Igoillo-Esteve, L. Marselli, D. A. Cunha, L. Ladrière, F. Ortis, F. A. Grieco, F. Dotta, G. C. Weir, P. Marchetti, D. L. Eizirik, M. Cnop
Erratum to: Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase
V. B. Matthews, M.-B. Åström, M. H. S. Chan, C. R. Bruce, K. S. Krabbe, O. Prelovsek, T. Åkerström, C. Yfanti, C. Broholm, O. H. Mortensen, M. Penkowa, P. Hojman, A. Zankari, M. J. Watt, H. Bruunsgaard, B. K. Pedersen, M. A. Febbraio